Clinical Trial Update: A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone) [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial of isatuximab with dexamethasone for relapsed multiple myeloma. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Isatuximab (isatuximab)

Snippet

Sponsor: EMN Trial Office S.r.l. Impresa Sociale | Conditions: Relapsed Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING